This inventor holds 10 USPTO granted patents. Top assignees: University of Utah Research Foundation, National Institute of Health and Medical Research, The Brigham and Women's Hospital, Inc.. Active years: 1994-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 1994-2010
Certainly! Here is the article about inventor Jean-Marc Lalouel:
Title: Innovator Spotlight: Jean-Marc Lalouel - Pioneering Advances in Drug Screening and Diagnosis
Introduction:
In the realm of healthcare innovation, inventor Jean-Marc Lalouel has been a trailblazer with his groundbreaking contributions to drug screening and diagnosis. Hailing from Salt Lake City, UT, Lalouel has amassed an impressive portfolio of 10 patents, with a focus on leveraging the tubular renin-angiotensinogen system for treating hypertension and assessing sodium status and sensitivity in individuals.
Latest Patents:
Lalouel's latest patents showcase his expertise in drug screening and diagnosis based on the paracrine tubular renin-angiotensin system. These inventions highlight his novel methods for evaluating the efficacy of drugs in hypertension treatment and determining sodium status and sensitivity through urinary angiotensinogen or angiotensin-I measurements.
Career Highlights:
Throughout his career, Lalouel has made significant strides in the field of biomedical research. He has been associated with esteemed institutions such as the University of Utah Research Foundation and Inserm, where he has spearheaded innovative projects that have the potential to revolutionize healthcare practices.
Collaborations:
Lalouel's collaborative efforts with renowned colleagues like Xavier Jeunemaitre and Richard P. Lifton have further enriched his contributions to the scientific community. Together, they have worked towards advancing the understanding of hypertension and developing targeted interventions for improved patient outcomes.
Conclusion:
In conclusion, Jean-Marc Lalouel stands as a distinguished innovator in the realm of drug screening and diagnosis, with a strong track record of transformative inventions that hold the promise of enhancing healthcare practices globally. His relentless pursuit of excellence and collaborative spirit exemplify the essence of innovation in driving positive change in the medical landscape.
Feel free to explore more about Jean-Marc Lalouel's pioneering work and patents on our website idiyas.com!
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile